TipRanks
Go Ultimate55% OFF

Compare TG Therapeutics (NKB2) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NKB2TG TherapeuticsEUR 54.80EUR 8.37B19.6988.19%Moderate BuyUnlock the DE:NKB2 analyst price target with TipRanks PremiumDE:NKB2Unlock the DE:NKB2 top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$141.40$9.37B114.4277.27%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumDE:NKB2 vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
IMVTImmunovant$29.03$6.03B-10.0715.11%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumDE:NKB2 vs IMVTUnlock the IMVT top-analyst price target with TipRanks Premium
ARQTArcutis Biotherapeutics$31.76$4.03B141.5823.51%Strong BuyUnlock the ARQT analyst price target with TipRanks PremiumDE:NKB2 vs ARQTUnlock the ARQT top-analyst price target with TipRanks Premium
LEGNLegend Biotech$21.27$4.19B-42.20-34.88%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumDE:NKB2 vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$125.73$10.81B-35.13106.19%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumDE:NKB2 vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NKB2TG Therapeutics54.8023.9077.37%
PTGXProtagonist Therapeutics139.3763.4283.50%
IMVTImmunovant28.414.6319.47%
ARQTArcutis Biotherapeutics31.266.5026.25%
LEGNLegend Biotech21.10-11.03-34.33%
KYMRKymera Therapeutics127.5167.79113.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts